Skip to main content
Fig. 2 | BMC Biology

Fig. 2

From: Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients

Fig. 2

Model validation. Model predictions compared to experimentally measured data (blue). All model adjustments and conversions are described in Additional File 2: Text S2. The bars represent the mean of the different data, while error bars indicate the range of the data (minimum and maximum). A Simulated NADH production flux, stoichiometrically converted to O2 consumption, compared to the uncoupled oxygen consumption flux of permeabilised MCAD-KO and control HepG2 cells. In converting an NADH production flux to an oxygen consumption flux, the contribution of FADH2 and reducing equivalents from the downstream TCA cycle were also considered (Additional File 2: Text S2). The experiment and simulation contained 25 µM of palmitoyl-CoA and 2 mM of L-carnitine (blue; n = 4 in both groups). B Simulated acetyl-CoA production flux, stoichiometrically converted to a ketogenic flux, compared to measured ketogenesis in 24 h-fasted, healthy human subjects (n = 17). C, D Comparison of simulated and measured palmitoyl-CoA (C16-CoA, C) and octanoyl-CoA (C8-CoA, D) dehydrogenation rates (acyl-CoA substrate at 30 µM) in crude lysate compared to cell lysates after immunoprecipitation of VLCAD or MCAD, respectively (blue; n = 3 or n = 4)

Back to article page